CareDx
CDNA
213 hedge funds and large institutions have $2.02B invested in CareDx in 2022 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 81 increasing their positions, 66 reducing their positions, and 38 closing their positions.
181% more call options, than puts
Call options by funds: $5.02M | Put options by funds: $1.78M
23% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 66
4.07% more ownership
Funds ownership: 102.35% → 106.42% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
5% less funds holding
Funds holding: 224 → 213 (-11)
17% less capital invested
Capital invested by funds: $2.45B → $2.02B (-$428M)
24% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$32.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$29.1M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$24.1M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$18.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$18.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$24.4M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$16.8M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$13.1M |
| 4 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$11.1M |
| 5 |
Millennium Management
New York
|
-$6.84M |
CDNA Hedge Fund Activity: Q1 2022 in Review
213 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in CareDx (CDNA) for Q1 2022, worth a combined $2.02B — down 17% from $2.45B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of CDNA and 29 opened new positions — a net loss of 9 holders — while 66 trimmed existing stakes and 81 added.
The largest buyer was Bellevue Group, adding an estimated $32.9M. The largest seller was Vanguard Group, cutting an estimated $24.4M.
- 213 institutional investors held CareDx (CDNA) as of Q1 2022, down from 224 in Q4 2021.
- Funds reported $2.02B of CareDx stock for Q1 2022, down 17% quarter-over-quarter.
- 29 funds opened new CareDx positions in Q1 2022 and 38 closed out, a net change of -9 holders.
- The largest CareDx buyer in Q1 2022 was Bellevue Group, an estimated $32.9M added.
- The largest CareDx seller in Q1 2022 was Vanguard Group, an estimated $24.4M sold.
Based on aggregated 13F filings for Q1 2022.